Nucleos(t)ide Analogue Treatment Cessation in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients: A Retrospective Single-center Study

Nucleos(t)ide Analogue Treatment Cessation in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients: A Retrospective Single-center Study

Introduction: The optimal duration of nucleos(t)ide analogues (NAs) therapy is unknown for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients. The European Association for the Study of the Liver (EASL) recommends the cessation of NAs in selected non-cirrhotic HBeAg-negative pa...

Full description

Bibliographic Details
Main Authors: Figen SARIGÜL, Ülkü USER
Format: Article
Language:Turkish
Published: Galenos Yayinevi 2020-12-01
Series:Mediterranean Journal of Infection, Microbes and Antimicrobials
Subjects:
chronic hepatitis b
hepatitis b e antigen
treatment cessation
Online Access:http://mjima.org/abstract.php?id=216

Similar Items

Similar Items